Immunization News and Research

RSS

Measles outbreak sends vaccine demand soaring, even among the hesitant

Demand for measles vaccine has surged in the Washington county where the highly contagious virus is linked to more than 50 confirmed illnesses this year — including among people who had previously shunned the shots.

6 Feb 2019

Measles outbreak in Clark County, Washington

A public health emergency has been declared in Washington with over two dozen cases of measles. Last Friday (25th January 2019), the Governor Jay Inslee said in a statement that there is an outbreak of measles and the Washington State Military Department and State Emergency Operations Center would be collaborating with the Department of Health to fight the outbreak.

28 Jan 2019

Thousands of girls in the UK have not been vaccinated against HPV

The PHE campaign to vaccinate all girls between the ages of 12 and 18 years against HPV was only achieved in two-thirds of the population between 2017-2018.

25 Jan 2019

Study demonstrates beneficial effects of influenza vaccination on COPD patients

A new study published in the January issue of CHEST establishes that patients with chronic obstructive pulmonary disease face heightened risks of death, critical illness, and hospitalization if they develop the flu and demonstrates the beneficial effects of influenza vaccination.

24 Jan 2019

A global influenza pandemic high on the WHO's agenda

Another influenza pandemic is on the third spot of the list of 10 health threats collated by the World Health Organization for 2019.

21 Jan 2019

Study finds critically low HPV vaccination rates among younger adolescents in the U.S.

Only about 16 percent of U.S. adolescents have been fully vaccinated against human papillomavirus (HPV) by the time they turn 13, despite national recommendations that call for vaccination at 11 to 12 years of age.

18 Jan 2019

Anti-vaccination movement one of the top health threats in 2019 says WHO

The World Health Organization (WHO) has created a list of health threats for the New Year. Interestingly, Anti-vaccination movement has featured among the top threats to the world. The anti-vaccination movement comprises of a group of people who are reluctant to getting vaccinated and refuse to vaccinate themselves or their children against vaccine preventable infections.

17 Jan 2019

Integrated care to women with PMADs offered at several levels

Over the past several decades, it's become increasingly recognized that perinatal mood and anxiety disorders, including postpartum depression, are more than just "baby blues."

17 Jan 2019

Study explores role of Dunning-Kruger effect in anti-vaccine attitudes

A study that helps explain why anti-vaccine attitudes still persist, despite clear evidence on the benefits of immunization to public health has been selected by an international scientific committee to be given the Atlas award.

16 Jan 2019

Educational videos in clinical settings increase HPV vaccination rates among adolescents

A study examining the effect of a video educational intervention aimed at increasing HPV vaccinations among adolescents could help the Centers for Disease Control and Prevention meet its goal of getting more eligible adolescents vaccinated against certain cancers and diseases caused by the human papillomavirus (HPV).

16 Jan 2019

New treatment for adults with rare, life-threatening blood disease receives FDA approval

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

21 Dec 2018

Pregnant women and extremely obese people at high risk of flu complications

Pregnant women and the extremely obese are among those at high risk for complications from the flu - including death - and should be tested and begin antiviral treatment promptly if they are sick enough to be hospitalized with flu symptoms, according to updated guidelines released by the Infectious Diseases Society of America.

19 Dec 2018

EU Member States fall short on influenza vaccination coverage for vulnerable groups, says ECDC

None of the European Union (EU) Member States could demonstrate that they reach the EU target of 75% influenza vaccination coverage for vulnerable groups, according to a new report from the European Centre for Disease Prevention and Control (ECDC).

19 Dec 2018

Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines

On Wednesday, December 12, 2018, Brazil's Butantan Institute signed a collaboration agreement with Merck Sharp & Dohme (MSD) to develop dengue vaccines.

12 Dec 2018

FSU study finds racial disparity among adolescents receiving flu vaccine

Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers.

11 Dec 2018

Reusable respirators can effectively protect health care workers from airborne contaminants

Half-facepiece reusable elastomeric respirators are an effective and viable option for protecting health care workers from exposure to airborne transmissible contaminants or infectious agents -- for example, influenza virus -- during day-to-day work or with a sudden or rapid influx of patients, such as during a public health emergency, says a new report from the National Academies of Sciences, Engineering, and Medicine.

7 Dec 2018

New study launched in Burkina Faso to test typhoid conjugate vaccine

A new study has been launched in Burkina Faso for Bharat Biotech's typhoid conjugate vaccine. It is the second clinical study underway in Africa for the vaccine and the first in West Africa.

4 Dec 2018

First modeling system developed for testing age-specific human immune responses to vaccines

A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines -- outside the body. The practical, cost-effective new platform, using all human components, is expected to accelerate and de-risk the development, assessment and selection of vaccines.

20 Nov 2018

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.

8 Nov 2018

Persuading more health workers to have flu jab needs new approach

Persuading more health workers across the continent to have the flu jab to protect themselves and their patients cannot be done through facts and statistics alone, new research by a leading behavioral scientist from Kingston University in London has revealed.

7 Nov 2018